A Artiva Biotherapeutics, Inc.: insider trades · United States · SEC (Form 4) Discover the full directors' dealings record of Artiva Biotherapeutics, Inc., a publicly traded company based in United States. Shares are quoted on US US, under the supervision of SEC (Form 4). Market capitalisation: €353.2m. The latest transaction was filed on 28 May 2026 (Acquisition). Among the most active insiders: GC Corp.. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 28 May 2026
All Executives21 Thresholds0 Prospectus0 Other0
Declarations 21 total
▲ 10% Owner · Executives · 11 May 2026
1,085,069 shares @ US$11.52 75.8% of flow Common Stock SEC:0001931382-26-000007:0
Ideal exit: 5 Feb 2027 (T+270) ▲ 10% Owner · Executives · 11 May 2026
347,222 shares @ US$11.52 24.2% of flow Common Stock SEC:0001931382-26-000007:1
Ideal exit: 5 Feb 2027 (T+270) ◆ Chief Medical Officer · Executives · 8 Apr 2025
50,000 shares 0Common Stock SEC:0001415889-25-011379:0
◆ President and CEO · Executives · 5 Mar 2025
200,000 shares 0Common Stock SEC:0001415889-25-007431:0
◆ COO, CLO, Secy, Compliance Off · Executives · 26 Feb 2025
86,650 shares 0Common Stock SEC:0001415889-25-006033:0
◆ Chief Tech Operations Officer · Executives · 26 Feb 2025
60,000 shares 0Common Stock SEC:0001415889-25-006035:0
◆ Chief Medical Officer · Executives · 26 Feb 2025
60,000 shares 0Common Stock SEC:0001415889-25-006036:0
◆ Chief Financial Officer · Executives · 26 Feb 2025
60,000 shares 0Common Stock SEC:0001415889-25-006034:0
◆ SVP, Research and Development · Executives · 26 Feb 2025
33,350 shares 0Common Stock SEC:0001415889-25-006037:0
◆ Chief Tech Operations Officer · Executives · 12 Sept 2024
25,000 shares 0Common Stock SEC:0001415889-24-023362:0
◆ Chief Financial Officer · Executives · 12 Sept 2024
50,000 shares 0Common Stock SEC:0001415889-24-023361:0
◆ COO, CLO, Secy, Compliance Off · Executives · 12 Sept 2024
50,000 shares 0Common Stock SEC:0001415889-24-023360:0
◆ SVP, Research and Development · Executives · 12 Sept 2024
10,000 shares 0Common Stock SEC:0001415889-24-023364:0
◆ Chief Medical Officer · Executives · 12 Sept 2024
20,000 shares 0Common Stock SEC:0001415889-24-023363:0
● Director · Executives · 22 Jul 2024
725,391 shares Common Stock SEC:0001415889-24-020047:0
1,058,284 shares Common Stock SEC:0001415889-24-020035:0
◆ President and CEO · Executives · 22 Jul 2024
228,905 shares 0Common Stock SEC:0001415889-24-019905:0
145,089 shares Common Stock SEC:0001415889-24-019908:0
● Director · Executives · 22 Jul 2024
667,185 shares Common Stock SEC:0001415889-24-019906:0
667,185 shares Common Stock SEC:0001415889-24-019907:0
843,592 shares Common Stock SEC:0000905148-24-001964:0